학술논문

Severe vascular calcification and tumoral calcinosis in a family with hyperphosphatemia: a fibroblast growth factor 23 mutation identified by exome sequencing
Document Type
article
Source
Nephrology Dialysis Transplantation. 29(12)
Subject
Rare Diseases
Genetics
Aetiology
2.1 Biological and endogenous factors
Adult
Alleles
Calcinosis
DNA
DNA Mutational Analysis
Enzyme-Linked Immunosorbent Assay
Exome
Female
Fibroblast Growth Factor-23
Fibroblast Growth Factors
Genotype
Humans
Hyperostosis
Cortical
Congenital
Hyperphosphatemia
Immunohistochemistry
Male
Mutation
Phosphates
Vascular Calcification
FGF23
hyperphosphatemia
vascular calcification
Clinical Sciences
Urology & Nephrology
Language
Abstract
BackgroundTumoral calcinosis is an autosomal recessive disorder characterized by ectopic calcification and hyperphosphatemia.MethodsWe describe a family with tumoral calcinosis requiring amputations. The predominant metabolic anomaly identified in three affected family members was hyperphosphatemia. Biochemical and phenotypic analysis of 13 kindred members, together with exome analysis of 6 members, was performed.ResultsWe identified a novel Q67K mutation in fibroblast growth factor 23 (FGF23), segregating with a null (deletion) allele on the other FGF23 homologue in three affected members. Affected siblings had high circulating plasma C-terminal FGF23 levels, but undetectable intact FGF23 or N-terminal FGF23, leading to loss of FGF23 function.ConclusionsThis suggests that in human, as in experimental models, severe prolonged hyperphosphatemia may be sufficient to produce bone differentiation proteins in vascular cells, and vascular calcification severe enough to require amputation. Genetic modifiers may contribute to the phenotypic variation within and between families.